KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NovoCure (NVCR) Interest Expenses (2016 - 2022)

Historic Interest Expenses for NovoCure (NVCR) over the last 9 years, with Q2 2022 value amounting to $2.2 million.

  • NovoCure's Interest Expenses rose 13702.13% to $2.2 million in Q2 2022 from the same period last year, while for Mar 2023 it was $2.2 million, marking a year-over-year decrease of 6725.94%. This contributed to the annual value of $7.7 million for FY2021, which is 3705.18% down from last year.
  • Latest data reveals that NovoCure reported Interest Expenses of $2.2 million as of Q2 2022, which was up 13702.13% from $1.7 million recorded in Q1 2022.
  • NovoCure's 5-year Interest Expenses high stood at $4.9 million for Q1 2018, and its period low was $940000.0 during Q2 2021.
  • For the 5-year period, NovoCure's Interest Expenses averaged around $2.5 million, with its median value being $2.4 million (2018).
  • In the last 5 years, NovoCure's Interest Expenses crashed by 6408.1% in 2021 and then surged by 13702.13% in 2022.
  • Quarter analysis of 5 years shows NovoCure's Interest Expenses stood at $2.2 million in 2018, then fell by 19.21% to $1.7 million in 2019, then soared by 87.22% to $3.3 million in 2020, then crashed by 33.43% to $2.2 million in 2021, then grew by 2.44% to $2.2 million in 2022.
  • Its Interest Expenses was $2.2 million in Q2 2022, compared to $1.7 million in Q1 2022 and $2.2 million in Q4 2021.